Moderna will supply up to 24 million doses of RSV vaccine to the European Union.

Gelonghui, July 10 — Moderna has announced that it has reached an agreement with the European Commission to supply up to 24 million doses of its mRESVIA vaccine, designed to prevent respiratory syncytial virus (RSV), to several EU countries. Under the contract, Moderna will deliver mRESVIA vaccines over four years to participating countries, including Austria, Denmark, Ireland, Luxembourg, Norway, and Portugal.